ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

DCPC Board Finally Approves Prescribe for Health Concept on 7-4 Vote, Okays RFA On Micronutrients

October 21, 1988

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988